Next Article in Journal
The Multifaceted Roles of Pyroptotic Cell Death Pathways in Cancer
Next Article in Special Issue
Panoptic View of Prognostic Models for Personalized Breast Cancer Management
Previous Article in Journal
The Impact of Flt3 Gene Mutations in Acute Promyelocytic Leukemia: A Meta-Analysis
Previous Article in Special Issue
Novel Biomarkers for Personalized Cancer Immunotherapy
Erratum published on 20 January 2020, see Cancers 2020, 12(1), 251.
Open AccessReview

Neuromedin U: A Small Peptide in the Big World of Cancer

1
Institute of Medical Biology, Polish Academy of Sciences, 106 Lodowa Str, 93-232 Lodz, Poland
2
Faculty of Biology and Environmental Protection, University of Lodz, 141/143 Pomorska Str, 90-236 Lodz, Poland
*
Authors to whom correspondence should be addressed.
Cancers 2019, 11(9), 1312; https://doi.org/10.3390/cancers11091312
Received: 29 July 2019 / Revised: 19 August 2019 / Accepted: 3 September 2019 / Published: 5 September 2019
(This article belongs to the Special Issue New Biomarkers in Cancers)
Neuromedin U (NMU), a neuropeptide isolated from porcine spinal cord and named because of its activity as a rat uterus smooth muscle contraction inducer, is emerging as a new player in the tumorigenesis and/or metastasis of many types of cancers. Expressed in a variety of tissues, NMU has been shown to possess many important activities in the central nervous system as well as on the periphery. Along with the main structural and functional features of NMU and its currently known receptors, we summarized a growing number of recently published data from different tissues and cells that associate NMU activity with cancer development and progression. We ask if, based on current reports, NMU can be included as a marker of these processes and/or considered as a therapeutic target. View Full-Text
Keywords: Neuromedin U; NMU; GPCR receptors; cancer Neuromedin U; NMU; GPCR receptors; cancer
Show Figures

Figure 1

MDPI and ACS Style

Przygodzka, P.; Soboska, K.; Sochacka, E.; Boncela, J. Neuromedin U: A Small Peptide in the Big World of Cancer. Cancers 2019, 11, 1312.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop